GlassScriptPhysician profile
Juan D Martinez
NPI 1245434810
$4,399.24
in general payments reported to CMS, 2019-2025
26 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,397 · 2020: $48.30 · 2021: $1,251 · 2022: $578 · 2023: $990 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659 · Travel and Lodging: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.34 |
| Travel and Lodging | $466.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,238.42 | 2021-2023 | Diamondback Coronary |
| Abiomed | $1,041.27 | 2019-2023 | Impella |
| Medtronic Vascular, INC. | $326.76 | 2019-2020 | |
| Bsn Medical INC | $186.48 | 2023 | |
| Novartis Pharmaceuticals Corporation | $176.90 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $150.76 | 2019-2023 | Xarelto |
| Teleflex LLC | $149.90 | 2019 | |
| Cardiovascular Systems INC. | $129.24 | 2019-2022 | |
| Boston Scientific Corporation | $121.26 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.09 | 2019-2022 | |
| Angiodynamics, INC. | $110.81 | 2022-2023 | Auryon Laser System 100-120 Vac |
| Cardiva Medical, INC. | $106.63 | 2022 | |
| Medtronic, INC. | $100.00 | 2021 | |
| Merck Sharp & Dohme LLC | $75.41 | 2022-2023 | Verquvo |
| Stryker Corporation | $60.07 | 2025 | Broadway 8 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $53.50 | 2025 | Entyvio, Eohilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.29 | 2022-2023 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $41.64 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.86 | 2023-2025 | Xifaxan |
| Shockwave Medical, INC | $29.70 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.53 | 2019 | |
| Amgen INC. | $18.67 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.12 | 2021 | |
| Pfizer INC. | $16.33 | 2023 | |
| Irhythm Technologies, INC. | $15.75 | 2022 | |
| Itamar Medical INC | $12.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.